menu
    • menu

    Company profile for XtalPi

    NEW Drugs in Dev: 2
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. With tightly interwoven quantum physics, AI, and high-performance cloud computing algorithms, XtalPi’s ID4 platform provides accurate predictions on the physicochemical and pharmaceutical properties of small-molecule candidates...
    XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. With tightly interwoven quantum physics, AI, and high-performance cloud computing algorithms, XtalPi’s ID4 platform provides accurate predictions on the physicochemical and pharmaceutical properties of small-molecule candidates for drug design, solid-form selection, and other critical aspects of drug development.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    XtalPiUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 Main St, 12th Floor, Cambridge MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xtalpi.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Asia Pharma Expo

    Not Confirmed

    envelop Contact Supplier

    Asia Pharma Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XtalPi Holdings Announces Full Year 2025 Annual Results
    XtalPi Holdings Announces Full Year 2025 Annual Results

    25 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/xtalpi-holdings-announces-full-year-2025-annual-results-302724963.html

    PR NEWSWIRE
    25 Mar 2026
    Share Share
    XtalPi Platform Advances Rare Neurology Drug RTX-117 to Clinic
    XtalPi Platform Advances Rare Neurology Drug RTX-117 to Clinic

    02 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/xtalpis-ai--robotics-platform-powers-first-clinical-milestone-for-revirs-rare-neurological-drug-rtx-117-302701177.html

    PR NEWSWIRE
    02 Mar 2026
    Share Share
    Xtalpi Hosts Global Experts To Advance Molecular Glue Drug
    Xtalpi Hosts Global Experts To Advance Molecular Glue Drug

    29 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/xtalpi-convenes-global-experts-to-shape-the-future-of-molecular-glue-drug-discovery-from-serendipity-to-precision-302673938.html

    PR NEWSWIRE
    29 Jan 2026
    Share Share
    Lilly Inks $345M Antibody Pact With Xtalpi Subsidiary
    Lilly Inks $345M Antibody Pact With Xtalpi Subsidiary

    06 Nov 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/lilly-expands-xtalpi-collaboration-345m-antibody-development-pact

    FIERCE BIOTECH
    06 Nov 2025
    Share Share
    XtalPi, PharmaEngine PRMT5 Inhibitor PEP08 in Trial
    XtalPi, PharmaEngine PRMT5 Inhibitor PEP08 in Trial

    09 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/xtalpi-ai-drug-discovery-collaboration-reaches-milestone-as-pharmaengines-novel-prmt5-inhibitor-pep08-receives-clinical-trial-approvals-302550869.html

    PR NEWSWIRE
    09 Sep 2025
    Share Share
    XtalPi and Dong-A ST Sign MOU for Immunology and Inflammation R&D
    XtalPi and Dong-A ST Sign MOU for Immunology and Inflammation R&D

    19 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/xtalpi-signs-mou-with-dong-a-st-for-joint-research-and-development-of-immunology-and-inflammation-therapies-302534023.html

    PR NEWSWIRE
    19 Aug 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search